The federal government indicated in a court filing last week that it will appeal the court’s decision striking down and vacating the government’s letter telling drug company AstraZeneca its conditions on 340B pricing when covered entities use contract pharmacy were illegal and had to stop. To facilitate an appeal, it asked the court to do nothing more in the case.
AstraZeneca meanwhile, in a Feb. 23 joint status report with the government to U.S. District Judge Leonard Stark of the District of Delaware, asked Stark to go beyond his Feb. 16 decision in the company’s case against the government. AstraZeneca asked him to:
The federal government indicated in a court filing last week that it will appeal the court’s decision striking down and vacating the government’s letter telling drug company AstraZeneca its conditions on 340B pricing when covered entities use contract pharmacy were illegal and had to stop.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
